Even after federal shortages of the most popular weight-loss drugs ended, many medical spas are still selling copycat ...

Despite the end of federal shortages of popular GLP-1 weight-loss medications, the market for compounded alternatives remains ...

Despite the end of federal shortages of popular GLP-1 weight-loss medications, the market for compounded alternatives remains ...

Add Yahoo as a preferred source to see more of our stories on Google. Wegovy and other injectable weight-loss medications have soared in popularity in the past two years. Supply issues and spotty ...

Despite the end of federal shortages of popular GLP-1 weight-loss medications, the market for compounded alternatives remains strong – and some patients may unknowingly be receiving products from ...

Compounded semaglutide, meanwhile, contains the same active ingredient as Ozempic, semaglutide. However, this medication is not approved by the FDA, and it may pose risks to those who take it, ...

Mon, February 10, 2025 at 4:52 AM UTC Some call these medications “generic Ozempic” (they’re not); others, “fake Ozempic” (nope, except when the ads are for illegal or nonexistent drugs). And last ...

Weight-loss treatments like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have been life changing for many individuals seeking to manage their weight. However, shortages and high ...

Advertisements for personalized GLP-1 weight-loss drugs are now as pervasive as they are dangerous. There’s already a robust national debate about direct-to-consumer pharmaceutical advertising. But ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Patients are being hospitalized with severe complications after ...

By Nqobile Dludla JOHANNESBURG, July 14 (Reuters) - South African pharmacy group iDexis said on Tuesday it had applied to appeal a court judgment that curbed its production of compounded weight-loss ...